Open access
Aug 2026
Circulating microRNAs as biomarkers of disease activity and treatment response in Crohn’s disease patients receiving infliximab or vedolizumab: a longitudinal cohort study
Serum miRNAs offer novel predictive and concurrent biomarker signals during biologic induction in Crohn’s disease, providing information complementary to faecal calprotectin.
Luisa Bertin, Lara Giraldi, Camilla Cavagna et al.
· Frontiers in Medicine · 0 citations